Interpace Biosciences, Inc. (IDXG)
OTCMKTS
· Delayed Price · Currency is USD
0.8100
+0.0300 (3.85%)
May 28, 2025, 12:49 PM EDT
Interpace Biosciences Market Cap
Interpace Biosciences has a market cap or net worth of $3.54 million as of May 29, 2025. Its market cap has decreased by -44.24% in one year.
Market Cap
3.54M
Enterprise Value
6.58M
Revenue
48.26M
Ranking
n/a
PE Ratio
2.37
Stock Price
$0.81
Market Cap Chart
Since May 20, 1998, Interpace Biosciences's market cap has decreased from 221.97M to 3.54M, a decrease of -98.41%. That is a compound annual growth rate of -14.19%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo Inc. | 1.63B |
Veradigm | 747.23M |
Nika Pharmaceuticals | 672.83M |
Tian'an Technology Group | 591.73M |
Elite Pharmaceuticals | 565.54M |
Glass House Brands | 452.21M |
CytoDyn | 423.89M |
Northwest Biotherapeutics | 399.83M |